In the most recent ONS Advocacy email, information from a study presented ASCO detailed unexpected effects of GLP-1s on reducing metastatic progression of certain cancers has created quite a stir. There are many things to be considered, while the study notes no significant safety concerns, expense and access still remain at the helm creating disparities. The steps to take to help patients receive these therapies have workplace impact. The ONS Health Policy Agenda 2026 has a great emphasis on...

ONS Has a podcast? There are a plethora of topics to listen to, one being ADVOCACY! Check out Episode 46: Nurse are Crucial in Local Advocacy Efforts . We have a voice for our patients, especially in our direct communities! https://www.ons.org/education-hub/oncology-nursing-podcast/episode-46-nurses-are-crucial-local-advocacy-efforts photo credit: https://www.trustedhealth.com/

Per LinkedIn, please read. To support and sign the petition click here: https://ana.quorum.us/campaign/professionaldegreepetition/